Testing metformin and NAC to help lung recovery after TB
Treatments studied
Part of Infections clinical trials.
This trial tests two drugs, metformin and N-acetylcysteine, to see if they can help your lungs work better after you finish tuberculosis treatment. You may join if you have active TB with lung damage and are starting standard TB therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 30 and 90 kilograms (66 to 198 pounds).
- You have active TB in your lungs that is sensitive to the antibiotic rifampin.
- Your lung function (FEV1) is 65% or less of what is expected for your age and height.
- You are not pregnant or planning pregnancy in the next 12 months and agree to use birth control if needed.
- You have not had TB treatment in the last 6 months except in the past 7 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests personalized TB treatment schedules based on your individual risk factors. Researchers want to see if matching treatment intensity to your specific situation helps cure TB while minimizing side effects.
This study tests new, faster ways to diagnose tuberculosis (TB) using samples like sputum (mucus from your lungs), tongue swabs, and urine. It aims to see if these new tests can find TB more accurately than current methods, which could help you get the right treatment sooner.
This trial tests whether adding omega-3 (fish oil) to standard TB treatment helps clear the infection faster and reduces inflammation. You may be eligible if you have confirmed lung TB and meet a few health criteria.
This trial tests if taking N-acetylcysteine (NAC) alongside standard TB treatment can help prevent long-term lung problems after tuberculosis. It is for people with moderate to severe TB who already have some reduced lung function.
This trial studies whether atorvastatin (a cholesterol medicine) can reduce ongoing inflammation after you finish standard tuberculosis (TB) treatment. If it works, it may improve how your body recovers after TB, especially by lowering inflammation-related signals.
This Phase 2 study tests treatment for people with newly diagnosed, drug-susceptible pulmonary (lung) tuberculosis (TB). It aims to see whether the study treatment works well and is safe for curing TB.
Hear when a new Tuberculosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.